Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mara J Horwitz

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Clinical Endocrinology|April 28, 2011
What medical options should be considered for the treatment of primary hyperparathyroidism?Mara J Horwitz
Current Osteoporosis Reports|October 1, 2013
Parathyroid hormone and parathyroid hormone-related protein analogs as therapies for osteoporosisMarilyn Augustine, Mara J Horwitz
The Journal of Clinical Endocrinology and Metabolism|September 6, 2008
Hypoparathyroidism: is it time for replacement therapy?Mara J Horwitz, Andrew F Stewart
Endocrinology|July 22, 2004
Parathyroid hormone-related protein: an essential physiological regulator of adult bone massAlessandro Bisello, Mara J Horwitz, Andrew F Stewart
The Journal of Clinical Endocrinology and Metabolism|February 8, 2003
Short-term, high-dose parathyroid hormone-related protein as a skeletal anabolic agent for the treatment of postmenopausal osteoporosisMara J Horwitz, Mary Beth Tedesco, Caren Gundberg, et al.
The Journal of Clinical Endocrinology and Metabolism|April 8, 2003
Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteersMara J Horwitz, Mary Beth Tedesco, Susan M Sereika, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 2013
Evaluation of markers of bone turnover during lactation in African-Americans: a comparison with Caucasian lactationRaquel M Carneiro, Linda Prebehalla, Mary Beth Tedesco, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 10, 2005
Safety and tolerability of subcutaneous PTHrP(1-36) in healthy human volunteers: a dose escalation studyMara J Horwitz, Mary Beth Tedesco, Susan M Sereika, et al.
Calcified Tissue International|August 28, 2023
Bone Mineral Density During and After Lactation: A Comparison of African American and Caucasian WomenMarilyn Augustine, Robert Boudreau, Jane A Cauley, et al.
The Journal of Clinical Endocrinology and Metabolism|April 13, 2010
The calcemic response to continuous parathyroid hormone (PTH)(1-34) infusion in end-stage kidney disease varies according to bone turnover: a potential role for PTH(7-84)Katherine Wesseling-Perry, G Chris Harkins, He-jing Wang, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Clinical Endocrinology|April 28, 2011
What medical options should be considered for the treatment of primary hyperparathyroidism?Mara J Horwitz
Current Osteoporosis Reports|October 1, 2013
Parathyroid hormone and parathyroid hormone-related protein analogs as therapies for osteoporosisMarilyn Augustine, Mara J Horwitz
The Journal of Clinical Endocrinology and Metabolism|September 6, 2008
Hypoparathyroidism: is it time for replacement therapy?Mara J Horwitz, Andrew F Stewart
Endocrinology|July 22, 2004
Parathyroid hormone-related protein: an essential physiological regulator of adult bone massAlessandro Bisello, Mara J Horwitz, Andrew F Stewart
The Journal of Clinical Endocrinology and Metabolism|February 8, 2003
Short-term, high-dose parathyroid hormone-related protein as a skeletal anabolic agent for the treatment of postmenopausal osteoporosisMara J Horwitz, Mary Beth Tedesco, Caren Gundberg, et al.
The Journal of Clinical Endocrinology and Metabolism|April 8, 2003
Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteersMara J Horwitz, Mary Beth Tedesco, Susan M Sereika, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 2013
Evaluation of markers of bone turnover during lactation in African-Americans: a comparison with Caucasian lactationRaquel M Carneiro, Linda Prebehalla, Mary Beth Tedesco, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 10, 2005
Safety and tolerability of subcutaneous PTHrP(1-36) in healthy human volunteers: a dose escalation studyMara J Horwitz, Mary Beth Tedesco, Susan M Sereika, et al.
Calcified Tissue International|August 28, 2023
Bone Mineral Density During and After Lactation: A Comparison of African American and Caucasian WomenMarilyn Augustine, Robert Boudreau, Jane A Cauley, et al.
The Journal of Clinical Endocrinology and Metabolism|April 13, 2010
The calcemic response to continuous parathyroid hormone (PTH)(1-34) infusion in end-stage kidney disease varies according to bone turnover: a potential role for PTH(7-84)Katherine Wesseling-Perry, G Chris Harkins, He-jing Wang, et al.
Pageof 2